Politics · India Bureau
Maharashtra Invests ₹1.2 Crore in Medicine Quality Checks Across Government Hospitals
Maharashtra has deployed advanced testing machines across its government hospital network to detect spurious and counterfeit medicines. The initiative aims to strengthen pharmaceutical quality assurance and protect patients from substandard drugs.
LSN India ·

Maharashtra's health department has rolled out high-tech machines worth ₹1.2 crore to bolster quality control mechanisms in government-run healthcare facilities. The deployment represents a significant step in the state's efforts to curb the circulation of spurious and counterfeit medicines within the public health system.
Healthcare Minister Prakash Abitkar has highlighted the critical role these devices will play in safeguarding patients and maintaining the integrity of pharmaceutical supplies. The testing equipment will enable rapid and accurate verification of medicine authenticity and quality at government hospitals, reducing the risk of patients receiving substandard or fake medications.
The initiative addresses growing concerns about counterfeit drugs entering the supply chain, a challenge that healthcare systems across India continue to grapple with. By establishing on-site testing capabilities, Maharashtra aims to create multiple checkpoints in the distribution process and enhance accountability at the hospital level.
The deployment of these machines is expected to streamline the verification process and provide healthcare staff with immediate confirmation of medicine authenticity before administration to patients. State officials view the investment as essential infrastructure for maintaining public trust in government healthcare services and ensuring treatment efficacy.